Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-09-18

Clinical Trial Update: SCID Bu/Flu/ATG Study With T Cell Depletion [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial update for SCID using Bu/Flu/ATG with T cell depletion; study terminated with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Neena Kapoor, M.D. | Conditions: Severe Combined Immunodeficiency | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2017-09-18